Clinical Trials Sponsored by AMO Pharma Limited

Total 171 results

AMO Pharma Limited

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (REACH CDM X)

Congenital Myotonic Dystrophy

United States, Canada, Australia, New Zealand
AMO Pharma Limited

Completed

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Congenital Myotonic Dystrophy

United States, Canada, New Zealand, Australia, United Kingdom
AMO Pharma Limited

Completed

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Myotonic Dystrophy 1

United Kingdom
invoX Pharma Limited

Recruiting

FS222 First in Human Study in Patients With Advanced Malignancies

Metastatic Cancer | Advanced Cancer

Spain, Romania
invoX Pharma Limited

Active, not recruiting

A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies

Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Advanced Cancer

United States, France
Teijin Pharma Limited

Completed

A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) (J-REPAIR)

Acute Ischemic Stroke

Japan
invoX Pharma Limited

Recruiting

Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

Melanoma | Solid Tumor | Head and Neck Squamous Cell Carcinoma

United States
Aerogen Pharma Limited

Completed

VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB

Pulmonary Hypertension

United States
Inotec AMD Limited

Withdrawn

Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers

Skin Ulcer Venous Stasis Chronic | Mixed Arteriovenous Leg Ulcer

Czechia
Proveca Pharma Limited

Recruiting

Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties, (SALIVA)

Neurodevelopmental Disorders | Sialorrhea

France
Aerogen Pharma Limited

Active, not recruiting

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

Respiratory Distress Syndrome in Premature Infant

United States, Canada
Novalead Pharma Private Limited

Unknown

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Malaysia, United States, India
Novalead Pharma Private Limited

Completed

Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers

Diabetic Foot Ulcer

India
CM&D Pharma Limited

Completed

Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence (CRC)

Adenocarcinoma of Colon Recurrent

Italy
Suzhou Zanrong Pharma Limited

Recruiting

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

United States
Suzhou Zanrong Pharma Limited

Recruiting

Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

China
Vectura Limited
UCB Pharma

Completed

An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma

Asthma

United Kingdom
Speciality European Pharma Limited

Completed

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

Prostate Cancer
AM-Pharma

Withdrawn

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia (SLIC)

Candidaemia

Netherlands
AM-Pharma

Terminated

A Study in Sepsis Patients With Renal Failure

Sepsis | Bacterial Infections and Mycoses

Netherlands, Belgium
AM-Pharma

Terminated

(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Acute Kidney Injury Due to Sepsis

Belgium, Spain, United States, Austria, Denmark, France, United Kingdom, Finland, New Zealand, Australia, Germany, Canada, Netherlands, Ireland, Japan
AM-Pharma

Withdrawn

Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

Fungal Infection | Bacterial Infection

Netherlands
AM-Pharma

Withdrawn

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (LIST)

Bacteremia | Staphylococcal Infections

Netherlands
AM-Pharma

Completed

Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients

Bacterial Infections and Mycoses | Hematopoietic Stem Cell Transplantation

Netherlands
Amryt Research Limited

Completed

Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE)

Epidermolysis Bullosa

United States, Spain, Israel, Australia, France, Denmark, Switzerland, Italy, Hong Kong, Argentina, Austria, Brazil, Chile, Colombia, Czechia, Georgia, Germany, Greece, Hungary, Ireland, Romania, Russian Federation, Serbia, Singapore, U... and more
Biota Pharma Europe Limited

Completed

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Respiratory Syncytial Virus (RSV) Infection

United Kingdom
Ten Sun Pharma Company Limited

Completed

Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins

Chronic Venous Insufficiency | Varicose Vein | Superficial Vein Thrombophlebitis

Taiwan
AM-Pharma

Completed

Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Hypophosphatasia

Germany
AM-Pharma

Completed

Recombinant Human Alkaline Phosphatase in Healthy Japanese Subjects

Healthy

Japan
AM-Pharma

Completed

Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis

Sepsis | Multiple Organ Dysfunction Syndrome

Netherlands, Belgium
Inotec AMD Limited
SerenaGroup, Inc.

Completed

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

Surgical Wound | Diabetic Foot Ulcer

United States, Puerto Rico
VA Pharma Limited Liability Company

Unknown

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

Safety Issues

Russian Federation
Sun Pharma Advanced Research Company Limited

Active, not recruiting

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Healthy (For Part A) | Chronic Myeloid Leukemia (for Part B and C)

United States, Spain, Hungary, Italy, India, Belgium, France, Romania, Singapore, United Kingdom, Korea, Republic of, Turkey
Mankind Pharma Limited
CBCC Global Research

Completed

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma (Glaucoma)

Glaucoma, Open-Angle

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety and Efficacy of PDP-716

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Efficacy and Safety of SDN-037

Inflammation and Pain Associated With Ocular Surgery

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

Multiple Myeloma
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of K0706 in Healthy Subjects

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 in Healthy Adult Volunteers

Healthy
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Healthy

Canada
Freed Study Group
Teijin Pharma Limited

Unknown

Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy (FREED)

Hyperuricemia

Japan
Proto Pharma Ltd
Xidea Solutions Limited

Completed

Efficacy of ArTiMist™ in Children

Falciparum Malaria
Sun Pharma Advanced Research Company Limited

Active, not recruiting

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Early Parkinson Disease

United States, Spain, India, Hungary, Slovakia, Poland
Aerogen Pharma Limited
Ohio State University

Completed

VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation (VPCOVID)

COVID-19

United States
Sun Pharma Advanced Research Company Limited

Completed

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Breast Cancer and Ovarian Cancer

Clinical Trials Sponsored by AMO Pharma Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations